Currently predicting for Thu, 4 Jun 2026

ABBV Prediction Chart

ABBV Predictions History

Latest community submissions for ABBV.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 20, 2024 Bullish $172.13 V 1
JS JS Pro
Apr 10, 2024 $170.37 +0.14% $169.03 X 99.21% 2
Apr 10, 2024 $171.46 +0.78% $169.03 X 98.56% 1
Apr 10, 2024 $170.97 +0.49% $169.03 X 98.85% 1
Mar 21, 2024 $177.47 +0.68% $177.50 V 99.98% 10
Mar 21, 2024 $177.02 +0.43% $177.50 V 99.73% 5
Mar 21, 2024 Bullish $177.50 V 1
Feb 9, 2024 $173.61 -0.67% $174.08 V 99.73% 5
Feb 9, 2024 $174.06 -0.42% $174.08 V 99.99% 10
Feb 9, 2024 Bullish $174.08 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ABBV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ABBVIE INC
AbbVie
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE